Ligand validation:7P59

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 7P59 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7P59_GLC_A_601	88%	62%	0.082	0.958	0.57	0.88	-	-	0	0	100%	0.9167
7P59_GLC_A_602	84%	50%	0.092	0.953	0.89	1.05	-	-	0	0	100%	0.9167
6ELC_GLC_A_605	83%	60%	0.101	0.959	0.61	0.91	-	-	0	0	100%	0.9167
7P5B_GLC_A_601	79%	47%	0.075	0.919	0.99	1.07	1	-	0	0	100%	0.9167
7P5A_GLC_A_601	34%	75%	0.251	0.935	0.26	0.7	-	-	0	0	100%	0.9167
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.